Cryo-Save India, the Indian subsidiary of Cryo-Save Group, announced their foray into the northern region of the country by launching a full-fledged marketing set-up in New Delhi. The new office is part of their strategic plan for India and is envisioned to further strengthen the company's position in the Indian market. To cater to parents growing need of providing bio-insurance to their offspring, Cryo-Save India has plans for a phased launch in key centres across the country. In the northern belt, the city of Delhi alone has 50,000 births per year in the Sec A & A+ category. The company's sales office is New Delhi and their northern region plans include representation in cities like Chandigarh, Jaipur, Lucknow, Indore soon.

Cryo-Save India, with its corporate office in Bangalore, was recently set up with an investment of 1.8 Million Euros. Cryo-Save Group will scale up its investment to 2 million Euros within a year of its operation of the Indian subsidiary. The group company, Europe's largest adult stem cell storage bank, has its operations in 37 countries across three continents. Cryo-Save India brings to the table a depth of expertise and experience in stem cell banking.

Cryo-Save India will be the only company in India with its unique offering of dual-storage system and this will be available for the first time in the country. They are also the only company that does automatic processing to avoid manual intervention and contamination. The company will be offering the collection and storage of adult stem cells derived from cord blood. The services will be available across all metros and other cities.

V R Chandramouli, managing director, Cryo-Save India, said, "We are very keen to extend our footprint to India specifically in the Delhi market as we see an immense market potential for adult stem cell banking or family banking in the Northern region. A world-class stem cell banking service was the need of the hour for a huge market like India and Cryo-Save India will be offering this. We believe that the launch of the Indian operations has ushered in a new chapter in the quality of stem cell banking services offered."

Stem cells are the natural repair kit of the human body. In the last 18 years more than 10000 patients have been treated with cord blood stem cells transplantations in over 150 countries. Umbilical cord blood stem cells have been used over the years in an increasing number of treatments including leukaemia, myelodysplastic syndrome, lymphomas, red cell disorders and more. Currently stem cell research is being done for more than 85 diseases.

Cryo-Save India is headquartered in Bangalore with a state-of-the art, one-of-its-kind, fully automated adult stem cell storage facility. The facility at Bangalore covers 10,000 sq ft with a storage capacity of 150,000 samples, extendable to 300,000 immediately.

Cryo-Save Group is Europe's largest adult stem cell storage bank, with more than 80,000 samples stored. The Company was established in 2000, is headquartered in The Netherlands, and owns or has access to, operating laboratory and storage facilities in Belgium, Germany and Dubai. Cryo-Save's services are available in 37 countries across three continents (Europe, Asia, and Africa).